Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Amodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 6 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/08/2021 40 43
Remdesivir Approved by FDA Experimental Antiviral Mar/05/2021 60 4
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Feb/16/2021 4 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Jan/25/2021 13 3
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021 12 1
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021 5 0